Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about Atopic Dermatitis and a new revision number, while significant details regarding a clinical trial for nemolizumab have been removed.SummaryDifference5%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.